{"id":197546,"date":"2026-06-26T00:00:00","date_gmt":"2026-06-26T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041802-medtech-dialysis-access-treatment-devices-market\/"},"modified":"2026-07-21T11:07:25","modified_gmt":"2026-07-21T11:07:25","slug":"48000646-medtech-dialysis-access-treatment-devices-market-insights-japan","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/48000646-medtech-dialysis-access-treatment-devices-market-insights-japan\/","title":{"rendered":"Dialysis Access Treatment Devices &#8211; Market Insights &#8211; Japan"},"content":{"rendered":"<p>The Japanese dialysis access treatment device market will <span>decline modestly<\/span> through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> and infectious disease impact. Favorable clinical trial outcomes demonstrating the benefits of <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s and covered stents for dialysis access maintenance will further support growth.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment devices in Japan from 2019 through 2035.<\/p>\n<p><strong>Recent M&#038;A activities and new product launches will lead to shifts in market shares going forward.<\/strong><\/p>\n<p>How have shares for competitors in the Japanese dialysis access treatment device market shifted recently?<\/p>\n<p>What acquisitions are positioning companies to enter high-growth segments?<\/p>\n<p>How are competitors leveraging portfolio expansions to strengthen their market position?<\/p>\n<p>How will emerging technologies introduce new competitive dynamics in the dialysis access device market, and which procedure groups will see the greatest impact from these new devices?<\/p>\n<p><strong>Th<\/strong><strong>e relaunch of Ellipsys will impact competitor and market dynamics in Japan.<\/strong><\/p>\n<p>How will the Ellipsys relaunch affect the percutaneous <abbr data-abbreviation-entity=\"8987\" title=\"Arteriovenous Fistula\">AVF<\/abbr> segment in Japan?<\/p>\n<p>Who are the emerging competitors in the percutaneous <abbr data-abbreviation-entity=\"8987\" title=\"Arteriovenous Fistula\">AVF<\/abbr> segment, and who will gain the first mover advantage in Japan?<\/p>\n<p><strong>Growth in the dialysis access maintenance device market will be supported by rising procedure volumes and increased use of premium-priced devices.<\/strong><\/p>\n<p>What impact will growing clinical evidence have on the adoption of premium-priced dialysis access maintenance devices?<\/p>\n<p>How will covered stents and <abbr data-abbreviation-entity=\"8827\" title=\"Drug-Coated Balloon\">DCB<\/abbr>s affect the dialysis access maintenance device segment?<\/p>\n","protected":false},"template":"","class_list":["post-197546","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-geography-japan","medtech-date-2828"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/197546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=197546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}